semaglutide and tachycardia increased heart rate with GLP1 meds #semaglutide #tirzepatide | heart palpitations Semaglutide in Patients With Obesity

These medications include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda), as well as the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist tirzepatide (Zepbound)

Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protection DOI: 10.1590/2175-8239-JBN-2020-0100 ABSTRACT Sodium glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1RA) were initially approved to improve glycemic control in the treatment of type 2 diabetes

Food and Drug administration, 2019

It occurs because Retatrutide affects gut motility and digestive function as part of its mechanism

Regulates Blood Sugar Semaglutide belongs to a class of medications called incretin mimetics